Medacta Corporate
BUSINESS WIRE: Medacta Announces FDA Clearance and First Surgeries Utilizing 3DMetal Tibial Cones for Knee Revision

BUSINESS WIRE: Medacta Announces FDA Clearance and First Surgeries Utilizing 3DMetal Tibial Cones for Knee Revision

November 03, 2017 08:00 AM Medacta International is proud to announce that the first two 3DMetal™ Tibial Cones surgeries have been performed by Kevin Hardt, MD and David Manning, MD from the Northwestern University Feinberg School of Medicine (Chicago, IL) and Jeremic Dragan, MD from St. Vinzenz Krankenhaus Brakel (Brakel, Germany).

 
3DMetal™ is a three-dimensional advanced biomaterial, based on 3D printing technology,  that enables direct structural and functional connection with the bone through an interconnecting pore structure similar to the cancellous bone structure. 
 
3DMetal™ Tibial Cones can be used for structural support in areas of tibial bone deficiencies that may compromise revision implant fixation. With this new solution, the Medacta knee portfolio is even more comprehensive, allowing surgeons to address multiple revision scenarios, even for the most challenging cases. 
 
Read more on BusinessWire